ACE2-derived peptides interact with the RBD domain of SARS-CoV-2 spike glycoprotein, disrupting the interaction with the human ACE2 receptor

Vaccines could be the solution to the current SARS-CoV-2 outbreak. However, some studies have shown that the immunological memory only lasts three months. Thus, it is imperative to develop pharmacological treatments to cope with COVID-19. Here, the in silico approach by molecular docking, dynamic si...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Biomol Struct Dyn
Autori principali: Souza, Pedro F. N., Amaral, Jackson L., Bezerra, Leandro P., Lopes, Francisco E. S., Freire, Valder N., Oliveira, Jose T. A., Freitas, Cleverson D. T.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Taylor & Francis 2021
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7876913/
https://ncbi.nlm.nih.gov/pubmed/33427102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/07391102.2020.1871415
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi